USE OF AN LTB4 ANTAGONIST FOR THE TREATMENT AND/OR PREVENTION OF DISEASES CAUSED BY INCREASED EXPRESSION OF MUCIN GENES

摘要

The invention relates to the use of a LTB4 antagonist or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment and/or prevention of diseases caused by increased expression of mucin genes and/or hyperplasia of goblet cells induced by toxins of products of pathogenic bacteria in the bronchial or gastrointestinal epithelium.